Evaluations of Sexual Dysfunction of Female in Chronic Renal Failure Clinical Trial
Official title:
Female Sexual Dysfunctions in Patients With Chronic Renal Failure
A myriad of sexual problems affect men and women with chronic kidney disease (CKD),
including decreased libido, erectile dysfunction, dysmenorrhea, and infertility. Menstrual
abnormalities are common in CKD and many women are an-ovulatory .
Causes of sexual dysfunction in CKD include hormonal alterations along with vascular,
neurologic, psychogenic, and other factors, such as medications, contribute to the
development of sexual dysfunction . Sexual dysfunction in females is mainly due to hormonal
factors and manifests mainly as menstrual irregularities, amenorrhea, lack of vaginal
lubrication, and failure to conceive.
Hormonal changes in chronic kidney disease are seen in prolactine, gonadotropins, and
gonadal hormones. In women with CKD, elevated levels of follicle-stimulating hormone (FSH)
and luteinizing hormone (LH) are common. These hormonal changes are detected in the early
stages of kidney disease and progressively worsen as kidney disease progresse .
. Women with chronic renal failure commonly have elevated circulating prolactin levels. As
in men with chronic renal failure, the hypersecretion of prolactin in this setting appears
to be autonomous, as it is resistant to maneuvers designed to stimulate or inhibit its
release.
It has been suggested that the elevated prolactin levels may impair hypothalamic-pituitary
function and contribute to sexual dysfunction and galactorrhea in these patients. However,
uremic women treated with bromocryptine rarely resume normal menses and continue to complain
of galactorrhea (if present), despite normalization of the plasma prolactin concentration.
Thus, factors other than hyperprolactinemia must be important in this setting .
;